@frankiemuniz Who are you and why is this in public? Act like an adult and deal with it personally not in a public forum you clickbait clown. No wonder why she divorced you. Get off my timeline
@ottermanic@BowTiedRanger Thanks! I do plan on reading the opinions for this case. Just a little depressed atm. But no blackpilling. America may be toast, but not Americans.
Here’s a cut covering what the Quran is, how Muslims understand its authorship, who secular historians think likely produced it, when it took shape, and how Jewish, Christian and apocryphal traditions shaped its contents.
It’s a useful introduction to Quranic textual criticism.
@JillFilipovic It just shows your deep anti-intellectual stance and a sincere lack of curiosity. Did you bother to even try Google Scholar? Here is the 3rd grade summary: https://t.co/4c9OWod1En
we are barely 6 months into 2026
here's some of the most unhinged biotech and longevity stuff this year alone:
- germline editing hit 100% efficiency with zero chromosomal abnormalities using base editing instead of CRISPR cutting
- a baby was born from an embryo selected for an IQ in the 99.99th percentile. the company behind it openly calls it eugenics
- Midjourney, an AI image company, pivoted into medical hardware with a full body ultrasound scanner that takes 60 seconds
- China reversed type 2 diabetes in a patient using stem-cell-derived insulin cells. insulin stopped completely. the body took over
- an Australian founder sequenced his dog's cancer, used AI to design a custom mRNA vaccine, and watched the tumor shrink
- daraxonrasib nearly doubled survival in pancreatic cancer. one of the deadliest cancers on earth. a 42 second standing ovation followed
- retatrutide hit 30% bodyweight loss in Phase 3. bariatric surgery territory from a peptide
- Eli Lilly bought Verve Therapeutics for $1B after one gene edit delivered permanent cholesterol reduction in human patients
- Life Biosciences dosed the first human with a therapy built to reverse cellular aging. the anti-aging era entered the clinic
- Demis Hassabis raised $2.1B for Isomorphic Labs on top of billions in pharma partnerships to build AI-designed drugs
- Brian Armstrong's NewLimit raised $435M at a $3.1B valuation to pursue cellular rejuvenation
- China launched a 2,000 person trial testing stem cells for age-related decline. the largest organized longevity study ever attempted
forget software
biology is now programmable
have you joined the cult?